We value your privacy

This website or its third-party tools process personal data. You can opt out of the sale of your personal information by clicking on the “Do Not Sell or Share My Personal Information” link.

Powered by

Descovy

ACNU Feasibility

View full report
ExcellentDescovy, an oral tablet for HIV/HBV, has mild side effects, low misuse risk, moderate drug interactions, and requires regular renal and HIV monitoring. Daily dosing is simple but adherence and special population caution are important per FDA ACNU safety and usability guidelines.

ACNU Feasibility Scorecard

Chart with 11 data points.
Descovy
The chart has 1 X axis displaying categories.
The chart has 1 Y axis displaying ← Lower is Better!. Data ranges from 1 to 6.
End of interactive chart.